Lipopolysaccharide (LPS) is the primary pathogenic factor in Gram-negative sepsis. While the presence of LPS in the bloodstream during infection is associated with disseminated intravascular coagulation, the mechanistic link between LPS and blood coagulation activation remains ill-defined. The contact pathway of coagulation-a series of biochemical reactions that initiates blood clotting when plasma factors XII (FXII) and XI (FXI), prekallikrein (PK), and high molecular weight kininogen interact with anionic surfaces-has been shown to be activated in Gram-negative septic patients. In this study, using an in vivo baboon model of Gram-negative Escherichia coli sepsis, we observed activation of the contact pathway including FXII, FXI, and PK. We examined whether E.coli LPS molecules could bind and activate contact pathway members by quantifying the interaction and activation of either FXII, FXI, or PK with each of the three chemotypes of LPS: O111:B4, O26:B6, or Rd2. The LPS chemotypes exhibited distinct physicochemical properties as aggregates and formed complexes with FXII, FXI, and PK. The LPS chemotype O26:B6 uniquely promoted the autoactivation of FXII to FXIIa and, in complex with FXIIa, promoted the cleavage of FXI and PK to generate FXIa and plasma kallikrein, respectively. Furthermore, in complex with the active forms of FXI or PK, LPS chemotypes were able to regulate the catalytic activity of FXIa and plasma kallikrein, respectively, despite the inability to promote the autoactivation of either zymogen. These data suggest that the procoagulant phenotype of E.coli is influenced by bacterial strain and the physicochemical properties of the LPS chemotypes.
5 July 2025 in Blood Vessels, Thrombosis & Hemostasis
The excessive inflammatory and prothrombotic response to a bacterial infection creates a life-threatening medical condition in sepsis. The transition from localized to systemic thrombin generation is a hallmark of disseminated intravascular coagulation (DIC), a severe prothrombotic disorder resulting in microvascular thrombosis and subsequent multiorgan failure. The contact pathway of coagulation has been shown to play roles both in the initiation and amplification of thrombin generation in models of sepsis. The contact pathway consists of the coagulation factors XII (FXII) and XI (FXI), prekallikrein, and high- molecular-weight kininogen. Activation of the contact pathway can be triggered by binding to anionic surfaces, such as the ionized phosphoryl and carboxylate groups present on bacterial surface macromolecules. In particular, FXII has been shown to bind to the components of the bacterial envelope, including adhesins, peptidoglycan, lipopolysaccharides from gram-negative bacteria, and lipoteichoic acids from gram-positive bacteria. This review discusses the molecular pathways linking activation of the contact pathway by the envelope structures of bacterial and downstream thrombin generation and inflammation associated with sepsis-induced coagulopathies. We highlight the potential for FXII and FXI as potential therapeutic options for safely preventing DIC in sepsis.
6 February 2025 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Lipopolysaccharide (LPS), a key component of the outer membrane of Gram-negative bacteria, is well-known for its role in triggering inflammation via innate immune receptors. However, evidence suggests that LPS can influence coagulation, in part through activation of the contact pathway. Recent studies from our group and others demonstrate that the supramolecular organization and physicochemical properties of LPS—such as aggregate size, surface charge, and chemotype—critically determine the ability of LPS to activate coagulation factor XII (FXII). While monomeric LPS can modulate FXII activity, only aggregated forms of LPS (e.g., micelles) function as a procoagulant surface, initiating contact activation. This review synthesizes current knowledge on LPS structural heterogeneity and explores how the biophysical properties of LPS govern supramolecular assembly in aqueous environments, ultimately dictating interactions with the contact activation pathway. We further discuss the possible mechanisms by which LPS-driven FXII activation contributes to thromboinflammatory disorders, including disseminated intravascular coagulation and sepsis-associated vascular leakage. Finally, we highlight novel therapeutic strategies—from FXIIa inhibitors to molecules that disrupt LPS supramolecular structures—as potential interventions to mitigate coagulation-driven pathology during bacterial infections. These insights not only reflect our growing understanding of infection-associated thrombosis but may also pave the way for targeted therapies in sepsis and other thromboinflammatory conditions.
Dysregulation of the coagulation pathway is a hallmark of endotoxemia and Gram-negative sepsis, leading to disseminated intravascular coagulation resulting from aberrant thrombin generation. Bacterial components such as lipopolysaccharides (LPS) have been shown to indirectly contribute to thrombin generation by activating or assembling members of the coagulation cascade in an LPS-chemotype dependent manner. Conversely, studies have shown that LPS may directly inhibit thrombin activity through an undefined mechanism. We studied whether the LPS chemotypes from bacteria including Escherichia coli (O111:B4, O26:B6), Klebsiella pneumoniae , and Pseudomonas aeruginosa bind and regulate thrombin activity. We found that these LPS chemotypes bound thrombin exosites via their polysaccharide regions. Only the E.coli O26:B6 and K.pneumoniae LPS chemotypes induced global structural changes in thrombin. Both the monomeric forms of E.coli O26:B6 and K.pneumoniae LPS chemotypes reduced the catalytic efficiency of thrombin and thrombin-dependent fibrin polymerization in purified systems. The E.coli O26:B6 LPS chemotype retained anticoagulant activity in plasma as an Ca 2+ -stabilized aggregate form. Our data suggests that select LPS chemotypes bind and inhibit the proteolytic activity of thrombin in a manner dependent on their supramolecular state. The heterogeneity of physicochemical properties of bacterial envelope components may contribute to the dysregulation of the coagulation pathway during endotoxemia.
Proteolytic reaction networks play vital roles in key biological processes like coagulation cascades, complement activation, and inflammatory signaling. However, accurately measuring the protease kinetics within these networks can be challenging. Traditional approaches often rely on measuring only the initial linear phase of the reaction, which can require large amounts of reagents and introduce variability due to subjective selection of early time points. This can reduce reproducibility, particularly when substrate concentrations decrease rapidly during the reaction. To overcome these challenges, we applied a mathematical framework based on the explicit Schnell–Mendoza solution of the integrated Michaelis–Menten equation. By using the Lambert function, this approach allows direct nonlinear fitting of entire reaction time courses without the need for complex root-finding or selecting initial velocities. We also incorporated the Goličnik analytical approximation as a simple and highly accurate alternative. Using representative coagulation proteases including human α-thrombin, factor XIa, and plasma kallikrein, we demonstrated that this method reliably estimates kinetic parameters ( and ), while reducing experimental effort, improving reproducibility, and enhancing analytical transparency. Importantly, the method remains robust under conditions where traditional initial-rate analyses are compromised by substrate depletion or poorly defined linear regions. Overall, this progress-curve approach provides a practical and efficient strategy for studying dynamical proteolytic systems. Beyond coagulation enzymes, the framework may be broadly applicable to enzyme network analysis, assay development, diagnostics, and molecular engineering in complex biological systems.